My main interest is providing the highest quality care to my patients using the latest minimally invasive procedures to treat peripheral vascular disease.
I received my Bachelor of Arts degree with honors in Chemistry and Philosophy from Johns Hopkins University in Baltimore, Maryland. I graduated from New York University School of Medicine in 1997 and then left “the city” to the cold of upstate New York.
I pursued my residency training in General Surgery at the University of Rochester in the Department of Surgery. During residency, I took a sabbatical as the “Harvard-Longwood Research Fellow in Vascular Surgery”. This fellowship is a highly selective and prestigious research fellowship in vascular surgery at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, Massachusetts. During this fellowship I performed research in the molecular biology of vascular disease. My research was supported by the National Institutes of Health.
I lectured across the country and published in numerous prestigious journals during this time. I returned to Rochester, New York to complete my general surgery training. During this busy time, I published several papers and lectured on minimally invasive treatments for peripheral vascular disease. I ventured out of the cold to the west coast (much to the delight of my wife) to learn the latest minimally invasive techniques in vascular and endovascular surgery at the University of California, San Francisco. I completed a fellowship in the highly acclaimed Department of Vascular and Interventional Radiology at UCSF. Then, I completed one of the premiere fellowships in the country in the world renowned Department of Vascular and Endovascular Surgery at UCSF.
I received unique hybrid fellowship training at UCSF in vascular and interventional radiology and vascular surgery in one of the only programs of its kind in the country allowing me to offer the full spectrum of treatment options from catheter based minimally invasive therapy (angioplasty and stents) to traditional operative therapy for patients with vascular disease.
I have been practicing at Kaiser Permanente since 2006.
My research interests include minimally invasive treatments for stroke and carotid artery disease, aortic and peripheral aneurysmal disease, and peripheral vascular disease. I have authored more than 30 articles in peer reviewed journals and lectured at several national meetings.
I serve as the technology lead for the department to help incorporate technology into our department’s practice.
- Kaiser Permanente Santa Clara Medical Center
- New York University School of Medicine, MD
- Johns Hopkins University, BA
- Published on 5/14/2013
Chang RW, Goodney P, Tucker LY, Okuhn S, Hua H, Rhoades A, Sivamurthy N, Hill B. Ten-year results of endovascular abdominal aortic aneurysm repair from a large multicenter registry. J Vasc Surg. 2013 Aug; 58(2):324-32. PMID: 23683376.
- Published on 1/24/2007
Hiramoto JS, Reilly LM, Schneider DB, Sivamurthy N, Rapp JH, Chuter TA. Long-term outcome and reintervention after endovascular abdominal aortic aneurysm repair using the Zenith stent graft. J Vasc Surg. 2007 Mar; 45(3):461-5; discussion 465-6. PMID: 17254734.
- Published on 7/1/2006
Sivamurthy N, Eichler C, Schneider DB. Endovascular exclusion of subclavian artery pseudoaneurysm. Vascular. 2006 Jul-Aug; 14(4):231-5. PMID: 17026916.
- Published on 4/21/2006
Sivamurthy N, Rhodes JM, Lee D, Waldman DL, Green RM, Davies MG. Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg. 2006 Jun; 202(6):859-67. PMID: 16735198.
- Published on 4/1/2006
Sivamurthy N, Schneider DB, Reilly LM, Rapp JH, Skovobogatyy H, Chuter TA. Adjunctive primary stenting of Zenith endograft limbs during endovascular abdominal aortic aneurysm repair: implications for limb patency. J Vasc Surg. 2006 Apr; 43(4):662-70. PMID: 16616217.
- Published on 7/1/2004
Surowiec SM, Fegley AJ, Tanski WJ, Sivamurthy N, Illig KA, Lee DE, Waldman DL, Green RM, Davies MG. Endovascular management of central venous stenoses in the hemodialysis patient: results of percutaneous therapy. Vasc Endovascular Surg. 2004 Jul-Aug; 38(4):349-54. PMID: 15306953.
- Published on 3/1/2004
Sivamurthy N, Surowiec SM, Culakova E, Rhodes JM, Lee D, Sternbach Y, Waldman DL, Green RM, Davies MG. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg. 2004 Mar; 39(3):565-74. PMID: 14981450.
- Published on 10/13/2003
Surowiec SM, Sivamurthy N, Rhodes JM, Lee DE, Waldman DL, Green RM, Davies MG. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg. 2003 Nov; 17(6):650-5. PMID: 14534846.
- Published on 6/1/2002
Sivamurthy N, Stone DH, LoGerfo FW, Quist WC. Attenuated retinoblastoma gene product and associated E2F/retinoblastoma imbalance in anastomotic intimal hyperplasia. J Vasc Surg. 2002 Jun; 35(6):1233-41. PMID: 12042736.
- Published on 1/1/2002
Stone D, Phaneuf M, Sivamurthy N, LoGerfo FW, Quist WC. A biologically active VEGF construct in vitro: implications for bioengineering-improved prosthetic vascular grafts. J Biomed Mater Res. 2002 Jan; 59(1):160-5. PMID: 11745549.
View 4 more publications: View full profile at BUMC